Cystic Kidney Diseases Associated with Increased Cancer Risk: Tuberous Sclerosis Complex, Von Hippel-Lindau, and Birt-Hogg-Dubé

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-4939-7784-0_3
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Optimal treatment of tuberous sclerosis complex associated renal angiomyolipomata: a systematic review

  2016cited by this paper
• Tumor Suppressor Folliculin Regulates mTORC1 through Primary Cilia*

  2016cited by this paper
• Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development

  2016cited by this paper
• Autosomal dominant polycystic kidney disease: the changing face of clinical management

  2015cited by this paper
• Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn

  2015cited by this paper
• Characterization of pulmonary cysts in Birt–Hogg–Dubé syndrome: histopathological and morphometric analysis of 229 pulmonary cysts from 50 unrelated patients

  2014cited by this paper
• Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study

  2014cited by this paper
• Blood pressure in early autosomal dominant polycystic kidney disease.

  2014cited by this paper
• Review of renal tumors associated with Birt-Hogg-Dubé syndrome with focus on clinical and pathobiological aspects.

  2014cited by this paper
• Intratumoral peripheral small papillary tufts: a diagnostic clue of renal tumors associated with Birt-Hogg-Dubé syndrome.

  2014cited by this paper
• Evidence for pericyte origin of TSC-associated renal angiomyolipomas and implications for angiotensin receptor inhibition therapy.

  2014cited by this paper
• Unique mutation, accelerated mTOR signaling and angiogenesis in the pulmonary cysts of Birt‐Hogg‐Dubé syndrome

  2013cited by this paper
• Performance of cystatin C-based equations in a pediatric cohort at high risk of kidney injury

  2013cited by this paper
• Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

  2013cited by this paper
• Dual-Tracer PET/CT in Renal Angiomyolipoma and Subtypes of Renal Cell Carcinoma

  2012cited by this paper
• Pulmonary Cysts of Birt-Hogg-Dubé Syndrome: A Clinicopathologic and Immunohistochemical Study of 9 Families

  2012cited by this paper
• Replication Fork Stalling and Checkpoint Activation by a PKD1 Locus Mirror Repeat Polypurine-Polypyrimidine (Pu-Py) Tract*

  2012cited by this paper
• Differentiation between Birt-Hogg-Dubé syndrome and lymphangioleiomyomatosis: quantitative analysis of pulmonary cysts on computed tomography of the chest in 66 females.

  2012cited by this paper
• Birt–Hogg–Dubé syndrome: clinicopathological features of the lung

  2012cited by this paper
• Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN.

  2012cited by this paper
• The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell development.

  2012cited by this paper
• Review of renal oncocytosis (multiple oncocytic lesions) with focus on clinical and pathobiological aspects.

  2012cited by this paper
• Recurrent spontaneous pneumothorax in a patient with Birt-Hogg-Dubé syndrome.

  2011cited by this paper
• Renal cancer and pneumothorax risk in Birt–Hogg–Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families

  2011cited by this paper
• HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression

  2011cited by this paper
• mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression.

  2011cited by this paper
• Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease.

  2011cited by this paper
• Cell Cycle Control and DNA Damage Response of Conditionally Immortalized Urothelial Cells

  2011cited by this paper
• Loss of primary cilia upregulates renal hypertrophic signaling and promotes cystogenesis.

  2011cited by this paper
• Primary cilia regulate mTORC1 activity and cell size through Lkb1

  2010cited by this paper
• Carboxy Terminal Tail of Polycystin-1 Regulates Localization of TSC2 to Repress mTOR

  2010cited by this paper
• The primary cilium: a signalling centre during vertebrate development

  2010cited by this paper
• The primary cilium at a glance

  2010cited by this paper
• Tuberous Sclerosis Complex: Neurological, Renal and Pulmonary Manifestations

  2010cited by this paper
• Tuberous Sclerosis Complex Renal Disease

  2010cited by this paper
• CAS proteins in normal and pathological cell growth control

  2010cited by this paper
• Primary cilia bend LKB1 and mTOR to their will.

  2010cited by this paper
• Glomerulocystic kidney disease

  2010cited by this paper
• Aberrant activation of fatty acid synthesis suppresses primary cilium formation and distorts tissue development.

  2010cited by this paper
• Lung cysts in Birt‐Hogg‐Dubé syndrome: Histopathological characteristics and aberrant sequence repeats

  2009cited by this paper
• The role of the Birt–Hogg–Dubé protein in mTOR activation and renal tumorigenesis

  2009cited by this paper
• Increased cancer risk of augmentation cystoplasty: possible role for hyperosmolal microenvironment on DNA damage recognition.

  2009cited by this paper
• Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2

  2009cited by this paper
• Renal involvement in tuberous sclerosis complex and von Hippel–Lindau disease: shared disease mechanisms?

  2009cited by this paper
• The primary cilium as a complex signaling center.

  2009cited by this paper
• New equations to estimate GFR in children with CKD.

  2009cited by this paper
• Zebrafish Tsc1 reveals functional interactions between the cilium and the TOR pathway.

  2009cited by this paper
• A new equation to estimate glomerular filtration rate.

  2009cited by this paper
• Renal tumour suppressor function of the Birt–Hogg–Dubé syndrome gene product folliculin

  2009cited by this paper
• RecQ and RecG helicases have distinct roles in maintaining the stability of polypurine.polypyrimidine sequences.

  2008cited by this paper
• Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal Neoplasia

  2008cited by this paper
• BHD mutations, clinical and molecular genetic investigations of Birt–Hogg–Dubé syndrome: a new series of 50 families and a review of published reports

  2008cited by this paper
• The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway

  2008cited by this paper
• Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia.

  2008cited by this paper
• Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys.

  2008cited by this paper
• Combined Vhlh and Pten Mutation Causes Genital Tract Cystadenoma and Squamous Metaplasia

  2008cited by this paper
• Correction: Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal Neoplasia

  2008cited by this paper
• Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of β-catenin in prostate cancer

  2008cited by this paper
• LKB1 modulates lung cancer differentiation and metastasis

  2007cited by this paper
• Regulation of epithelial tight junction assembly and disassembly by AMP-activated protein kinase

  2007cited by this paper
• Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dubé syndrome.

  2007cited by this paper
• The VHL Tumor Suppressor: Riding Tandem with GSK3β in Primary Cilium Maintenance

  2007cited by this paper
• Cancer Statistics, 2006

  2006cited by this paper
• The Primary Cilium as the Cell's Antenna: Signaling at a Sensory Organelle

  2006cited by this paper
• The tuberous sclerosis complex.

  2006cited by this paper
• Hamartin, the tuberous sclerosis complex 1 gene product, interacts with polo-like kinase 1 in a phosphorylation-dependent manner.

  2006cited by this paper
• The von Hippel-Lindau tumor suppressor protein controls ciliogenesis by orienting microtubule growth

  2006cited by this paper
• Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling

  2006cited by this paper
• Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein.

  2006cited by this paper
• Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor.

  2006cited by this paper
• A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma

  2006cited by this paper
• Primary cilium formation requires von hippel-lindau gene function in renal-derived cells.

  2006cited by this paper
• Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors.

  2006cited by this paper
• Mechanism of von Hippel-Lindau Protein-Mediated Suppression of Nuclear Factor kappa B Activity

  2005cited by this paper
• Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndrome.

  2005cited by this paper
• Tuberose sclerosis complex: analysis of growth rates aids differentiation of renal cell carcinoma from atypical or minimal-fat-containing angiomyolipoma.

  2005cited by this paper
• Proline hydroxylation and gene expression.

  2005cited by this paper
• Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL-/- renal cancer.

  2005cited by this paper
• von Hippel-Lindau tumor suppressor: not only HIF's executioner.

  2004cited by this paper
• The von Hippel-Lindau tumor suppressor protein influences microtubule dynamics at the cell periphery.

  2004cited by this paper
• PKD1 intron 21: triplex DNA formation and effect on replication.

  2004cited by this paper
• Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL

  2003cited by this paper
• The vertebrate primary cilium is a sensory organelle.

  2003cited by this paper
• The International Child Neurology Association: Personal View

  2003cited by this paper
• Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene.

  2003cited by this paper
• The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathway.

  2003cited by this paper
• Epilepsy, Atherosclerosis, Myocardial Infarction, and Carbamazepine

  2003cited by this paper
• Hypoxia Inducible Factor Activates the Transforming Growth Factor-α/Epidermal Growth Factor Receptor Growth Stimulatory Pathway in VHL-/- Renal Cell Carcinoma Cells*

  2003cited by this paper
• Molecular basis of the VHL hereditary cancer syndrome

  2002cited by this paper
• Retention of membrane‐localized β‐catenin in cells lacking functional polycystin‐1 and tuberin

  2002cited by this paper
• Clinical and genetic studies of Birt-Hogg-Dubé syndrome

  2002cited by this paper
• Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome.

  2002cited by this paper
• HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron.

  2002cited by this paper
• Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome.

  2002cited by this paper
• Renal Tumors in the Birt-Hogg-Dubé Syndrome

  2002cited by this paper
• Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease.

  2001cited by this paper
• Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.

  2001cited by this paper
• Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.

  2001cited by this paper
• Time to treat polycystic kidney diseases like the neoplastic disorders that they are.

  2000cited by this paper
• Requirement for the von Hippel-Lindau tumor suppressor gene for functional epidermal growth factor receptor blockade by monoclonal antibody C225 in renal cell carcinoma.

  2000cited by this paper

• Tuberous sclerosis complex exhibits a new renal cystogenic mechanism

  2019cites this paper
• Renal manifestation of tuberous sclerosis complex

  2018influential citation